Research reveals that reducing anticholinergic burden can significantly enhance cognitive function in patients with psychosis, offering new treatment insights.
Justin Allen, MD
Advertisement
Articles by Justin Allen, MD
Ketamine or ECT? A new study reveals which works best for severe depression—depending on the patient and setting.
How efficacious is brexpiprazole as a treatment for agitation associated with Alzheimer disease?
Advertisement
Latest Updated Articles
Exploring the Role of Brexpiprazole in Alzheimer Dementia AgitationPublished: January 16th 2024 | Updated:
Clinical Features Associated With Response to Ketamine vs Electroconvulsive Therapy for Treatment-Resistant DepressionPublished: March 19th 2025 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
Lifestyle Psychiatry for Supporting Individuals With Major Depressive Disorder
2
APSARD 2026: Emerging Data Challenge Long-Held Concerns About ADHD Treatment
3
Busting ADHD Myths at APSARD
4
New ADHD Medications Discussed at APSARD 2026
5